NASDAQ: EYEG       Eyegate Pharma
Last Price Today's Change   Day's Range   Trading Volume
6.404   +0.054 (0.85%)  6.35 - 6.441  9,481


Avg Volume (4 weeks):2,733,250
4 Weeks Range:3.56 - 8.18
4 Weeks Price Volatility (%):
52 Weeks Range:3.20 - 8.18
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Eyegate Pharmaceuticals Inc is a US-based clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company’s lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1814  4335  477  3253 

Top 10 Active Counters
 SNDL 0.733+0.043 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 BNGO 8.495+1.545 
 AVGR 1.51+0.40 
 BB 10.71+1.60 
 CTRM 0.333-0.027 
 NIO 57.32-3.55 
 HTZ 0.00-1.75 
 GPOR 0.1380.00 


1. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
2. Equities Retreated on Waning Optimism State of The Markets
3. CryptoNews of the Week CryptoNews
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast